ECE2021 Audio Eposter Presentations Thyroid (157 abstracts)
Antithyroid drugs as treatment of neutropenia in hyperthyroidism
Sawsen Essayeh 1 , Manel Jemel 2 , Hiba Chatti 1 , Wiem Madhi 1 , Radhouane Gharbi 2 , Hajer Kandara 2 & Ines Kammoun 2
1National Institute of Nutrition and Food Technology, Department of Endocrinology, Tunis, Tunisia; 2National Institute of Nutrition and Food Technology El Manar University, Department of Endocrinology, Tunis, Tunisia
Introduction
Hematological abnormalities are frequently observed in hyperthyroidism and are part of complex, multifactorial pathogenetic mechanisms that are still poorly understood, which can affect the three hematopoietic lineages in isolation or in combination. For the endocrinologist, they raise the issue of the risk of their aggravation under the hamatotoxic effect of antithyroid drugs (ATDs).
Case presentation
A 28-year-old man, with no particular past medical history, presented palpitations with irritability and weight loss. Hormonal tests revealed hyperthyroidism: free thyroxine (FT4) =38 pmol/l (reference: 8.6–25 pmol/l) and thyroid stimulating-hormone (TSH) < 0.005 µUI/ml (reference: 0.4–4 µUI/ml). The physical examination didn’t find a goiter or eye signs. TSH receptor autoantibodies were positive at 12, 6 UI/l (reference: <1 UI/l). Therefore, the diagnosis of Graves ’disease was made. The complete blood count (CBC) showed a neutropenia with polynuclear neutrophils (PNN) = 800/mm3 controlled at 850/mm3. After obtaining the consent of the patient, a treatment with ATDs was started and the CBC after five days of treatment showed PNN at 1080/mm3 and 1200/mm3 after 12 days. The ATDs were maintained and the PNN were 2300/mm3 after euthyroidism.
Conclusion
The threshold of neutropenia contraindicating the prescription of ATDs could well be lowered with vigilance and warning of the patient. Some authors speak of the physiological phenomenon of margination of white blood cells falsely underestimating the count of the lineage, a situation worsened by hyperthyroidism but bot contraindicating the introduction of ATD.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more